Interstitial pneumonitis associated with infliximab therapy

Journal of Rheumatology

Volumn 33, Issue 6, 2006, Pages 1189-1193

  Villeneuve, Edith ^a   St Pierre, Anne ^a,b   Haraoui, Boulos ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Department of Rheumatology ^*  (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

Infliximab; Methotrexate; Pneumonitis; Rheumatoid arthritis

Indexed keywords

CASPOFUNGIN; INFLIXIMAB; ITRACONAZOLE; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; OXYGEN; PREDNISONE;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG TOXICITY; MALE; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; METHOTREXATE; PREDNISOLONE; RADIOGRAPHY, THORACIC;

EID: 33744720092     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kremer JM, Alarcon GS, Weinblatt ME, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 1997;40:1829-37.
2. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipient. J Infect Dis 2002;186:1297-306.
3. Kramer N, Chuzhin Y, Kaufman L, Ritter J, Rosenstein ED. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2002;47:670-1.
4. Courtney PA, Alderdice J, Whitehead EM. Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis [letter]. Kramer N, Chuzhin Y, Kaufman L, Ritter J, Rosenstein ED [reply]. Arthritis Rheum 2003;49:617-8.
5. Chatterjee S. Severe interstitial pneumonitis associated with infliximab therapy. Scand J Rheumatol 2004;33:276-7.
6. Saravanan V, Kelly CA. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology Oxford 2004;43:143-7.
7. Kamata Y, Nara H, Kamimura T, et al. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 2004;43:1201-4.
8. Dotan I, Yeshurun D, Hallak A, et al. Treatment of Crohn's disease with anti TNF alpha antibodies -the experience in the Tel Aviv Medical Center. Harefuah 2001;140:289-93.
9. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
10. Kuroki M, Noguchi Y, Shimono M, et al. Repression of bleomycin-induced pneumopathy by TNF. J Immunol 2003;170:567-74.
11. Catrina AI, Trollmo C, afKlint E, et al. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum 2005;52:61-72.
12. Van den Brande JMH, Braat H, van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003;124:1774-85.
13. Clewes AR, Dawson JK. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis [letter]. Saravanan V, Dixit A, Kelly CA [reply]. Rheumatology Oxford 2004;43:1059-60.